Vapor products; modifying and adding requirements for certain attestation; requiring certain notice and directing seizure of certain products. Emergency.
What changed between versions
Critical compliance deadlines were moved forward from September 1, 2026, to September 1, 2025, in multiple sections of the bill.
A new mandatory annual attestation process was established, requiring manufacturers to submit sworn statements to the Attorney General certifying their product's FDA status.
New fees were introduced for the attestation process: a $5,000 initial fee and a $2,500 annual renewal fee for each manufacturer.
Clear definitions were added for 'vapor product' and 'timely filed premarket tobacco product application' to clarify which items are subject to the new rules.
The document structure was changed from a committee amendment format to a formal Senate Floor version, incorporating bolded text to denote specific committee amendments.